Association of Androgen Receptor, Prostate-Specific Antigen, and CYP19 Gene Polymorphisms with Prostate Carcinoma and Benign Prostatic Hyperplasia in a North Indian Population

被引:13
作者
Soni, Abha [1 ]
Bansal, Anju [1 ]
Mishra, Ashwani Kumar [1 ]
Batra, Jyotsna [2 ,3 ]
Singh, Laishram Chandreshwor [1 ]
Chakraborty, Anurupa [1 ]
Yadav, Dhirendra Singh [1 ]
Mohanty, Nayan K. [4 ,5 ]
Saxena, Sunita [1 ]
机构
[1] Natl Inst Pathol ICMR, New Delhi 110029, India
[2] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia
[3] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia
[4] Safdarjang Hosp, Dept Urol, New Delhi, India
[5] Vardhman Mahavir Med Coll, New Delhi, India
基金
澳大利亚国家健康与医学研究理事会;
关键词
CAG REPEAT LENGTH; CANCER; RISK; AROMATASE; PSA; IDENTIFICATION; EXPRESSION; IMPACT; GGN;
D O I
10.1089/gtmb.2011.0322
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The genes involved in androgen pathway and metabolism have been reported to contribute considerably to prostate carcinoma (CaP) risk. The present study investigated the association of androgen receptor (AR), prostate-specific antigen (PSA or KLK3), and cytochrome P450 (CYP19) gene polymorphisms in CaP (n = 105) and benign prostatic hyperplasia (BPH) (n = 120) in comparison to normal healthy controls (n = 106) in an Indian population. We also evaluated the functional consequences of these gene variants on AR and PSA mRNA expression. Significant association of short AR CAG repeats (<= 24) with risk of CaP (odds ratios [OR] = 2.98, p < 0.001) and BPH (OR = 1.96, p = 0.01) was observed; however, CYP19 gene polymorphism was not found to be associated with disease phenotype (p > 0.05). PSA G-158A SNP was found to be significantly associated with risk of CaP (AA: OR = 2.68, p = 0.016 and GA: OR = 2.07, p = 0.018) p-trend 0.031 and BPH (AA: OR = 3.46, p < 0.001 and GA: OR = 2.47, p = 0.03) p-trend 0.009, respectively. PSA G-158A genotype independently increased the risk of developing BPH (OR = 16.37, p < 0.001), irrespective of AR CAG repeat length. Using quantitative real-time polymerase chain reaction, we found a significant upregulation of AR and PSA mRNA expression in CaP comparison to BPH. While short AR CAG (<= 24) repeats were associated with higher AR mRNA expression in CaP (p = 0.002), the PSA SNP did not correlate with its mRNA expression. Interestingly, significantly higher risk estimates for CaP were observed for the combined analysis of short AR CAG and CYP19 genotypes (A2A2) (OR = 7.18, p < 0.001) or A2A3 (OR = 7.60, p = 0.004). Our results suggest significant association of androgen signaling gene polymorphisms with risk of CaP and BPH and provide evidence for a putative functional role of AR CAG repeat in regulating its mRNA expression and warrant the need of larger studies in the Indian population to confirm our results.
引用
收藏
页码:835 / 840
页数:6
相关论文
共 36 条
  • [1] Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men
    Balic, I
    Graham, ST
    Troyer, DA
    Higgins, BA
    Pollock, BH
    Johnson-Pais, TL
    Thompson, IM
    Leach, RJ
    [J]. JOURNAL OF UROLOGY, 2002, 168 (05) : 2245 - 2248
  • [2] GENERAL METHOD FOR ISOLATION OF HIGH MOLECULAR-WEIGHT DNA FROM EUKARYOTES
    BLIN, N
    STAFFORD, DW
    [J]. NUCLEIC ACIDS RESEARCH, 1976, 3 (09) : 2303 - 2308
  • [3] Contribution of the androgen receptor to prostate cancer predisposition and progression
    Buchanan, G
    Irvine, RA
    Coetzee, GA
    Tilley, WD
    [J]. CANCER AND METASTASIS REVIEWS, 2001, 20 (3-4) : 207 - 223
  • [4] The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer
    Chiang, CH
    Chen, KK
    Chang, LS
    Hong, CJ
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04) : 1529 - 1532
  • [5] Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: The hidden face of estrogens
    Cussenot, Olivier
    Azzouzi, Abdel Rhamene
    Nicolaiew, Nathalie
    Fromont, Gaelle
    Mangin, Philippe
    Cormier, Luc
    Fournier, Georges
    Valeri, Antoine
    Larre, Stephane
    Thibault, Frederic
    Giordanella, Jean-Pierre
    Pouchard, Michel
    Zheng, Yan
    Hamdy, Freddie C.
    Cox, Angela
    Cancel-Tassin, Geraldine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3596 - 3602
  • [6] Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population
    dos Santos, ML
    Sarkis, AS
    Nishimoto, IN
    Nagai, MA
    [J]. CANCER DETECTION AND PREVENTION, 2003, 27 (05): : 321 - 326
  • [7] PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy
    dos Santos, Rodrigo Mattos
    Nobrega de Jesus, Carlos Marcio
    Souza Trindade Filho, Jose Carlos
    Souza Trindade, Jose Carlos
    Viana de Camargo, Joao Lauro
    Rainho, Claudia Aparecida
    Rogatto, Silvia Regina
    [J]. DNA AND CELL BIOLOGY, 2008, 27 (09) : 497 - 503
  • [8] Local aromatase expression in human prostate is altered in malignancy
    Ellem, SJ
    Schmitt, JF
    Pedersen, JS
    Frydenberg, M
    Risbridger, GP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05) : 2434 - 2441
  • [9] Treating prostate cancer: A rationale for targeting local oestrogens
    Ellem, Stuart J.
    Risbridger, Gail P.
    [J]. NATURE REVIEWS CANCER, 2007, 7 (08) : 621 - 627
  • [10] Prognostic value of microvessel density in prostate cancer: a tissue microarray study
    Erbersdobler, Andreas
    Isbarn, Hendrik
    Dix, Kira
    Steiner, Isabel
    Schlomm, Thorsten
    Mirlacher, Martina
    Sauter, Guido
    Haese, Alexander
    [J]. WORLD JOURNAL OF UROLOGY, 2010, 28 (06) : 687 - 692